Pluromed, Inc. develops, manufactures, and markets disposable medical devices based on reverse thermosensitive polymer technology in Europe, Canada, and the United States. It offers LeGoo Internal Vessel Occluder, a liquid polymer for the temporary occlusion of blood vessels; and LeGoo Endovascular Occlusion Gel for clampless vascular and cardiovascular surgery. The company also provides BackStop, an atraumatic device to prevent stone migration and stone fragment retropulsion during ureteroscopic lithotripsy; and Lumagel, an oncology product for cancer therapies, partial nephrectomy, hepatic resection, radiofrequency ablation, and chemotherapy. Its products are used to control bleeding during various surgical and interventional procedures including cardiac and vascular surgery, plastic and reconstructive surgery, kidney and liver cancer therapies, and trauma/battlefield injuries. The company was founded in 2003 and is based in Woburn, Massachusetts. As of April 2, 2012, Pluromed, Inc. operates as a subsidiary of Sanofi.

Tokyo Gas Co., Ltd. engages in the provision of city gas and other gas-related products. It operates through the following segments: Gas, Electric Power, Overseas Business, Energy-related, Real Estate, and Others. The Gas segment produces, supplies, and sells city gas and liquid gas. The Electric Power segment handles electric power services. The Overseas Business segment deals with overseas resource development, investment, and energy. The Energy-related segment includes engineering solutions, gas appliances, and gas construction works. The Real Estate segment leases and manages land and buildings. The Others segment includes information processing service and shipping businesses. The company was founded by Eiichi Shibusawa on October 1, 1885 and is headquartered in Tokyo, Japan.

Beijing Richen-Force Science & Technology Co., Ltd was founded in July 2002. With the mission of “develop national medical technology and serve for the well-being of all mankind”, we have been specializing in R&D, manufacturing, marketing and customer service of high-tech medical devices in Gastroenterology field more than 10 years. Now besides our headquarters in Beijing, we Richen Group have established R&D Center and Production Bases in Beijing, Guangzhou and Taizhou, and meanwhile we have set up our subsidiary companies in Italy (www.richeneurope.eu) and Brazil, Research Center in USA. Until now our 13C-UBT products have been exported to more than 60 countries, and we have more than 6000 customers in the global market. Our 13C-UBT Diagnostic Products (13C Urea Breath Test Kits and 13C Infrared Spectrometers) have been developed since 2004, featuring non-invasive, painless, safe and easy to use. Because of high sensitivity and specificity, 13C-UBT has become the golden standard of H. Pylori diagnosis, completely in accordance with international concepts. Through more than ten years development, the concept of “Just take a breath and then diagnose the diseases” has struck root into people’s minds. Richen Group now owns 70% of market share in China, which makes it become one of the most competitive enterprises for 13C-UBT Technology in the world.

Jiangsu Huagen Tailai Biotechnology Co., Ltd., established on 2013-01-16, Business scope includes pharmaceuticals,Technology development of medical devices,technical consulting,Technical service and technology transfer;Granule production,Production of raw materials,Sales,one,two,Production of Class III Medical Devices,Sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Zhejiang Jingxin Shupai Medical Technology Co., Ltd., established on 2017-01-11, Business scope includes technology development,Technical Services,technical consulting,Achievement transfer:medical technology,No. I,II,Class III medical device,computer network Technology,Equipment,communication equipment,Computer hardware and software;Sales:No. I,II,Class III medical device,Equipment,communication equipment,Computer hardware and software;Serve:Business Management Consulting,Economic Information Consulting;Technology Import and Export(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license)

Notre Dame Intermédica Participações SA provides healthcare plans and medical services. It also operates hospitals and clinic centers. The company was founded by Paulo Sergio Barros Barbanti in 1968 and is headquartered in São Paulo, Brazil.

Taizhou Enze Medical Center is a Chinese private company located in Linhai that operates general medical and surgical hospitals.

Quanfeng Technology (Shenzhen) Co., Ltd., established on 2020-08-12, Business scope includes general business items:Biotechnology,new material technology,Promotion of Energy Saving Technology;Technical development of biological products;Technology development of biotechnology products;Science and Technology Information Consulting;Scientific research and development and technical service industry(None of the above items are restricted).,The licensing program is:none

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.

Huai'an First People's Hospital, a subsidiary of Nanjing Medical University, is a Chinese company located in Huai'an. The firm provides healthcare services.